Ex Parte Letts - Page 2


                Appeal 2007-1392                                                                             
                Application 10/640,895                                                                       

                only claims pending in this application. 2  We have jurisdiction pursuant to                 
                35 U.S.C. § 6.                                                                               
                      According to Appellant, the invention is directed to a method for                      
                producing polyisocyanurate insulation foams, the method comprising                           
                contacting an isocyanate-reactive compound with an isocyanate compound                       
                in the presence of a blowing agent.  The blowing agent comprises isopentane                  
                and n-pentane in the substantial absence of cyclopentane (Br. 2).3  Claim 7                  
                is representative of the invention and is reproduced below:                                  
                7.  A method for producing polyisocyanurate insulation foams, the                            
                      method comprising:                                                                     
                            contacting an isocyanate-reactive compound with an isocyanate                    
                      compound in the presence of a blowing agent that includes both                         
                      isopentane and n-pentane in the substantial absence of cyclopentane,                   
                      where the isopentane is present in a weight fraction that is greater than              
                      the weight fraction of the n-pentane.                                                  
                      The Examiner has relied on the following prior art references as                       
                evidence of unpatentability:                                                                 
                Smits     US 5,387,618   Feb. 7, 1995                                                        
                Imperial Chemical PCT WO 97/121764   Jun. 19, 1997                                           
                Soukup     US 6,140,383   Oct. 31, 2000                                                      


                                                                                                            
                2 We refer to the claims as presented in the Revised Appeal Brief.                           
                Appellant’s representative indicated at the oral hearing that the claims                     
                presented in the Reply Brief are in error and have not been presented for                    
                review.                                                                                      
                3 We refer to and cite from Appellant’s “Revised Appeal Brief” dated May                     
                22, 2006 and the Reply Brief dated October 16, 2006.                                         
                                                     2                                                       

Page:  Previous  1  2  3  4  5  6  7  8  9  Next

Last modified: September 9, 2013